chest pain post-op - Nursing Case Study

Pathophysiology

• Primary mechanism: Myocardial ischemia - Reduced blood flow to the heart muscle due to stress or clot formation post-surgery can cause ischemia, leading to chest pain as the heart struggles to receive adequate oxygen.

• Secondary mechanism: Pulmonary embolism - A blood clot may form in the deep veins (often in the legs) and travel to the lungs, causing blockage in the pulmonary artery. This can lead to chest pain, shortness of breath, and decreased oxygenation.

• Key complication: Postoperative atelectasis - Collapse of lung tissue due to anesthesia effects and reduced mobility can cause hypoxia and chest discomfort, complicating recovery if not addressed promptly.

Patient Profile

Demographics:

65-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, recent coronary artery bypass graft (CABG) surgery

• Current medications: Metformin, Lisinopril, Metoprolol, Aspirin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Moderate chest pain at the surgical site, shortness of breath, mild swelling in the lower extremities

• Vital signs: Blood pressure 150/90 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 100.4°F, oxygen saturation 92% on room air

Section 1

Change in Patient Status:

As the afternoon progresses, the patient begins exhibiting worsening symptoms. Her chest pain intensifies, now described as sharp and radiating to her back, and her shortness of breath becomes more pronounced. Her respiratory rate increases to 28 breaths per minute, and her oxygen saturation drops to 88% despite supplemental oxygen via nasal cannula. Her blood pressure remains elevated at 155/95 mmHg, and her heart rate increases to 120 bpm, indicating potential hemodynamic instability. She appears visibly anxious and is using accessory muscles to breathe, suggesting increased respiratory effort.

On further assessment, the nurse notes that the patient's jugular veins are distended, and there is an increase in the swelling of her lower extremities. Auscultation reveals diminished breath sounds at the bases with faint crackles, particularly on the right side, raising concern for pulmonary complications. The patient's temperature remains elevated at 100.6°F, indicating a potential inflammatory or infectious process. These findings prompt the healthcare team to prioritize further diagnostic testing, including an urgent chest X-ray and arterial blood gas analysis, to evaluate for possible pulmonary embolism or other respiratory complications. The evolving clinical picture necessitates a reassessment of her current management plan, focusing on stabilizing her respiratory and hemodynamic status while investigating the underlying cause of her symptoms.

Section 2

New Diagnostic Results:

As the healthcare team swiftly proceeds with the diagnostic workup, the initial results begin to shed light on the patient's deteriorating condition. The chest X-ray reveals a prominent opacity in the right lower lung field, suggestive of either a consolidation or possible atelectasis. This finding aligns with the diminished breath sounds and faint crackles auscultated earlier. Additionally, the arterial blood gas analysis shows a respiratory acidosis with a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, confirming the patient's compromised respiratory function and insufficient gas exchange.

Further blood tests reveal an elevated D-dimer level of 2.5 μg/mL (normal < 0.5 μg/mL), raising suspicion for a thromboembolic event, such as a pulmonary embolism. Coupled with the clinical signs of jugular venous distension and tachycardia, these results prompt the team to consider an urgent CT pulmonary angiography to confirm the presence of a clot in the pulmonary vasculature. Meanwhile, the patient's elevated white blood cell count at 15,000 cells/μL suggests an inflammatory or infectious process, which could be contributing to the fever and respiratory distress.

The integration of these diagnostic findings necessitates a reassessment of the patient's management plan. The team deliberates the initiation of anticoagulation therapy while balancing the risks and benefits, given the potential for a pulmonary embolism. Concurrently, they address the underlying infection with broad-spectrum antibiotics until further cultures can pinpoint the causative organism. The evolving clinical picture underscores the importance of vigilant monitoring and timely interventions to prevent further complications and stabilize the patient's condition. As the team implements these strategies, they remain poised to adjust the treatment plan based on the forthcoming CT results and the patient's response to the initial interventions.

Section 3

As the healthcare team implements the initial interventions for the suspected pulmonary embolism and potential infection, close monitoring of the patient's status becomes paramount. Within a few hours, the patient's condition shows mixed responses to the treatment regimen. The initiation of anticoagulation therapy with low-molecular-weight heparin appears to stabilize his cardiovascular status. His heart rate has decreased slightly to 98 beats per minute, and his blood pressure remains stable at 125/78 mmHg, providing some reassurance that the risk of further clot propagation is being managed.

However, despite the commencement of broad-spectrum antibiotics, the patient's fever persists, with his temperature peaking at 38.9°C (102°F). His respiratory status continues to be a concern; he remains tachypneic with a respiratory rate of 28 breaths per minute, and his oxygen saturation is fluctuating around 88% on 4L of supplemental oxygen via nasal cannula. Repeat arterial blood gas analysis shows minimal improvement, revealing a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 64 mmHg, indicating ongoing respiratory compromise and the need for possible escalation in respiratory support.

As the team awaits the CT pulmonary angiography results, they remain vigilant for signs of new complications. The patient's persistent fever and elevated white blood cell count, now at 16,500 cells/μL, suggest that the infection may be more severe or atypical. The team considers the possibility of an abscess or resistant organism. The decision is made to obtain blood cultures and re-evaluate the patient's antibiotic regimen based on microbial sensitivity results once available. The unfolding scenario underscores the importance of adaptive clinical reasoning, as the team works to identify and address the multifaceted challenges impacting the patient's recovery trajectory.

Section 4

As the medical team reviews the CT pulmonary angiography results, they confirm the presence of a moderate-sized pulmonary embolism in the right lower lobe, aligning with the initial suspicion. This finding further justifies the continuation of anticoagulation therapy, which has shown effectiveness in stabilizing the patient’s cardiovascular status. However, the team remains attentive to the patient's unresolving respiratory distress and considers the need for more aggressive respiratory support. The decision is made to transition the patient from nasal cannula to a non-rebreather mask, increasing the oxygen flow to 15L/min to improve his oxygen saturation levels, which subsequently rise to 92%.

Simultaneously, the team receives preliminary results from the blood cultures, revealing the presence of methicillin-resistant Staphylococcus aureus (MRSA). This development necessitates an immediate adjustment in the antibiotic regimen. The patient is promptly started on vancomycin, targeting the resistant organism more effectively. The healthcare team discusses the possibility of a deep-seated infection or abscess, particularly given the persistent fever and elevated white blood cell count. A focused ultrasound of the chest and abdomen is proposed to rule out any potential abscess formations that might require drainage or further intervention.

Throughout these developments, the patient's overall status presents a complex interplay of improvement and ongoing challenges. While cardiovascular stability is achieved, and adjustments in respiratory support show initial positive effects, the infection remains a critical concern. The scenario emphasizes the need for continuous reassessment and adaptability in clinical decision-making, as the team navigates through the intertwined issues of thromboembolism, respiratory compromise, and a resistant infection. The next steps involve close monitoring of the patient's response to the revised antibiotic therapy and reassessment of his respiratory status to determine if further escalation, such as non-invasive ventilation or intensive care support, might be necessary.

Section 5

As the healthcare team continues to monitor the patient, a significant change in his status becomes evident. Despite the adjustments in respiratory support and the initiation of vancomycin therapy, the patient begins to exhibit signs of increasing respiratory distress. His respiratory rate climbs to 30 breaths per minute, and he develops accessory muscle use, indicating heightened respiratory effort. His oxygen saturation drops to 88% despite the use of a non-rebreather mask, prompting immediate concern. The nursing staff notes an increase in the patient's heart rate to 120 beats per minute and a blood pressure reading of 100/60 mmHg, suggesting potential hemodynamic instability.

In response to the patient's deteriorating respiratory condition, the team decides to initiate non-invasive ventilation (NIV) to provide more effective respiratory support. A BiPAP machine is set up, delivering a higher level of positive airway pressure to assist with ventilation and improve oxygenation. Concurrently, the medical team orders a repeat arterial blood gas analysis, which reveals a pH of 7.32, a pCO2 of 55 mmHg, and a pO2 of 58 mmHg, indicating respiratory acidosis with hypoxemia. These findings corroborate the need for escalated respiratory intervention.

As the patient adjusts to the BiPAP, his oxygen saturation begins to stabilize around 94%, and his respiratory rate gradually decreases to 24 breaths per minute, providing a temporary reprieve. The team conducts a thorough reassessment to identify potential underlying causes for the sudden respiratory decline. A chest X-ray is ordered to evaluate for possible atelectasis or worsening pulmonary embolism and to ensure proper BiPAP mask fit and function. The interdisciplinary team remains vigilant, recognizing that further complications such as ventilator-associated pneumonia or worsening of the embolic event could still arise. The next steps involve close observation of his response to the NIV, ongoing assessment of his infection status, and preparedness for rapid intervention should his condition further deteriorate.